Summary of Purpose
Use of intravenous (IV) thrombolysis and intra-arterial (IA) recanalization treatment has been rapidly increasing, However, despite of the treatment, recanalization rates are 22.6 - 70% and only 30-50% of patients show meaningful clinical improvements. Mechanisms of futile recanalization may include 1) large ischemic core, 2) poor collateral, and 3) presence of comorbidity. In this regards, developing selection...Read More →
The following dates are available for this trial. Trial information last updated on 23 November 2016.
|1 Nov 2016||7 Nov 2016||1 Jul 2018||1 Oct 2018||1 Nov 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Yonsei University Lead
- Hyo Suk Nam, MD